日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

YTHDF2 promotes ATP synthesis and immune evasion in B cell malignancies

YTHDF2促进B细胞恶性肿瘤中的ATP合成和免疫逃逸。

Zhenhua Chen,Chengwu Zeng,Lu Yang,Yuan Che,Meiling Chen,Lillian Sau,Bintao Wang,Keren Zhou,Yu Chen,Ying Qing,Chao Shen,Tingjian Zhang,Mark Wunderlich,Dong Wu,Wei Li,Kitty Wang,Keith Leung,Miao Sun,Tingting Tang,Xin He,Lianjun Zhang,Srividya Swaminathan,James C Mulloy,Markus Müschen,Huilin Huang,Hengyou Weng,Gang Xiao,Xiaolan Deng,Jianjun Chen

m6A/YTHDF2-mediated mRNA decay targets TGF-β signaling to suppress the quiescence acquisition of early postnatal mouse hippocampal NSCs

m6A/YTHDF2介导的mRNA衰变靶向TGF-β信号通路,抑制小鼠出生后早期海马神经干细胞的静止状态获得。

Feng Zhang ,Yao Fu ,Dennisse Jimenez-Cyrus ,Ting Zhao ,Yachen Shen ,Yusha Sun ,Zhijian Zhang ,Qing Wang ,Riki Kawaguchi ,Daniel H Geschwind ,Chuan He ,Guo-Li Ming ,Hongjun Song

YTHDF2 regulates self non-coding RNA metabolism to control inflammation and tumorigenesis

YTHDF2通过调节自身非编码RNA代谢来控制炎症和肿瘤发生

Seungwon Yang # ,Yan-Hong Cui # ,Haixia Li # ,Jiangbo Wei # ,Gayoung Park ,Ming Sun ,Michelle Verghese ,Emma Wilkinson ,Teresa Nam ,Linnea Louise Lungstrom ,Xiaolong Cui ,Tae Young Ryu ,Jing Chen ,Marc Bissonnette ,Chuan He ,Yu-Ying He

Targeting YTHDF2 with pH-responsive siRNA nanoparticles suppresses MYC m6A modification and restores antitumor immunity in hepatocellular carcinoma

利用pH响应性siRNA纳米颗粒靶向YTHDF2可抑制MYC m6A修饰并恢复肝细胞癌的抗肿瘤免疫力。

Ziqi Guo,Qiuling Huang,Zhenzhen Cui,Cheng Yang,Liu Yang

YTHDF2 in peritumoral hepatocytes mediates chemotherapy-induced antitumor immune responses through CX3CL1-mediated CD8+ T cell recruitment

肿瘤周围肝细胞中的YTHDF2通过CX3CL1介导的CD8+ T细胞募集,介导化疗诱导的抗肿瘤免疫反应。

Zhenyun Yang # ,Xin Wang # ,Yizhen Fu # ,Weijie Wu # ,Zili Hu ,Qingyang Lin ,Wei Peng ,Yangxun Pan ,Juncheng Wang ,Jinbin Chen ,Dandan Hu ,Zhongguo Zhou ,Li Xu ,Yaojun Zhang ,Jiajie Hou ,Minshan Chen

The tumor-intrinsic role of the m6A reader YTHDF2 in regulating immune evasion

m6A 阅读蛋白 YTHDF2 在调节免疫逃逸中的肿瘤内在作用

Sai Xiao ,Shoubao Ma ,Baofa Sun ,Wenchen Pu ,Songqi Duan ,Jingjing Han ,Yaqun Hong ,Jianying Zhang ,Yong Peng ,Chuan He ,Ping Yi ,Michael A Caligiuri ,Jianhua Yu

YTHDF2 favors protumoral macrophage polarization and implies poor survival outcomes in triple negative breast cancer

YTHDF2 促进肿瘤巨噬细胞极化,并预示着三阴性乳腺癌患者预后不良。

Hao Jin ,Yue Chen ,Dongbo Zhang ,Junfan Lin ,Songyin Huang ,Xiaohua Wu ,Wen Deng ,Jiandong Huang ,Yandan Yao

YTHDF2 inhibition potentiates radiotherapy antitumor efficacy

YTHDF2抑制剂可增强放射疗法的抗肿瘤疗效

Liangliang Wang ,Xiaoyang Dou ,Shijie Chen ,Xianbin Yu ,Xiaona Huang ,Linda Zhang ,Yantao Chen ,Jiaai Wang ,Kaiting Yang ,Jason Bugno ,Sean Pitroda ,Xingchen Ding ,Andras Piffko ,Wei Si ,Chao Chen ,Hualiang Jiang ,Bing Zhou ,Steven J Chmura ,Cheng Luo ,Hua Laura Liang ,Chuan He ,Ralph R Weichselbaum

O-GlcNAcylation of YTHDF2 promotes HBV-related hepatocellular carcinoma progression in an N6-methyladenosine-dependent manner

YTHDF2 的 O-GlcNAc 糖基化以 N6-甲基腺苷依赖的方式促进 HBV 相关肝细胞癌的进展。

Yang Yang # ,Yu Yan # ,Jiaxin Yin # ,Ni Tang # ,Kai Wang # ,Luyi Huang ,Jie Hu ,Zhongqi Feng ,Qingzhu Gao ,Ailong Huang

YTHDF2/m6 A/NF-κB axis controls anti-tumor immunity by regulating intratumoral Tregs

YTHDF2/m6 A/NF-κB轴通过调节肿瘤内Treg细胞来控制抗肿瘤免疫

Linda Zhang,Xiaoyang Dou,Zhong Zheng,Chang Ye,Thomas X Lu,Hua L Liang,Liangliang Wang,Ralph R Weichselbaum,Chuan He